Lupin’s Somerset facility gets 13 observations post US FDA inspection
The company does not believe that this will have an impact on disruption of supplies or the existing revenues from operations of…
Author
Rethink, Reapply and Reboot
Ankit Goyal, Healthcare and Lifesciences Practice Leader India, Heidrick & Struggles, enlarges on the changes in work trends…
Healthcare industry reports 86 deals worth $25.5 billion in Oct 2020
Three major deals contributes 72 per cent of total deal value
Bharat Biotech to manufacture Covaxin from Odisha
Dr Ella informs that the best of the technology will be put in the Odisha unit at a total investment of around Rs 300 crores
Biocon Biologics gets Rs 1, 125 cr capital injection from Goldman Sachs
Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion
Humanigen announces positive interim data of Lenzilumab in hospitalised COVID-19 patients
The company intends to file for EUA in the first quarter of 2021 either following interim data at 75 per cent or at study…
Bristol Myers Squibb get EC approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) with…
Opdivo plus Yervoy-based combinations now indicated in the EU for three different advanced cancer types: non-small cell lung…
Thermo Fisher Scientific, Innoforce to set up biologics and steriles drug manufacturing facility in…
The new facility is expected to be completed in 2022
Celltrion presents data for COVID-19 monoclonal antibody treatment candidate CT-P59
It demonstrated promising safety, tolerability, antiviral effect, and efficacy profile of CT-P59 in patients with mild symptoms of…
Jubilant Pharma and Aavis Pharma launch Hydroxychloroquine Sulfate tablets in US
The product will be distributed by Jubilant Cadista, a unit of Jubilant Pharma